17 results
20-F/A
2020 FY
BPTS
Biophytis
28 Oct 21
Annual report (foreign) (amended)
5:16pm
suspend or terminate a clinical study based on evolving business objectives and/or competitive climate.
Submission of an NDA to the FDA
Assuming
20-F
2020 FY
BPTS
Biophytis
12 Mar 21
Annual report (foreign)
2:38pm
objectives and/or competitive climate.
Submission of an NDA to the FDA
Assuming successful completion of all required testing in accordance with all
424B4
skf1jc nwr
11 Feb 21
Prospectus supplement with pricing info
12:00am
F-1/A
fzgb 93ugwvnmu
4 Feb 21
Registration statement (foreign) (amended)
2:42pm
F-1/A
aty1 0jpphkzm7to
2 Feb 21
Registration statement (foreign) (amended)
5:27pm
F-1
rd6ab0ksddpbqz0p99zp
19 Jan 21
Registration statement (foreign)
5:05pm
DRS/A
ztlldgo
23 Dec 20
Draft registration statement (amended)
12:00am
DRS
3lx6fng5dfl
20 Nov 20
Draft registration statement
12:00am
F-1/A
lqona qgi5s9o
11 Jul 19
Registration statement (foreign) (amended)
5:32pm
F-1/A
pqhd20u0cndf
8 Jul 19
Registration statement (foreign) (amended)
5:15pm
F-1/A
0a8hcf6qwevxrz
24 Jun 19
Registration statement (foreign) (amended)
4:31pm
F-1/A
6g9lwp
12 Jun 19
Registration statement (foreign) (amended)
5:19pm
F-1
coywy09pka7ykqxh6s
21 May 19
Registration statement (foreign)
9:06pm
DRS
ikrg61h9i 52e
25 Feb 19
Draft registration statement
12:00am
- Prev
- 1
- Next